Back to search
FDAFDA · Food and drugs·Recall number D-0333-2026

acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56

Published February 18, 2026 · Recall initiated: February 5, 2026

Summary

FDA records drug Class II recall D-0333-2026, published February 18, 2026 and initiated February 5, 2026. Recalling firm: Fresenius Kabi Compounding, LLC; Status: Ongoing; Reported quantity: 1057 bags; Lot: Lot # C274-000049124, Exp Date: 28-Feb-26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi Compounding, LLC
Distributor
US Nationwide.
Lot
Lot # C274-000049124, Exp Date: 28-Feb-26.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56 recalled?

Yes. FDA published recall D-0333-2026 on February 18, 2026. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter